1-3 of 3
Mark K Polar
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Epcoritamab with R-CHOP Overcomes Poor Risk Features of High Total Metabolic Tumor Volume in High-Risk Large B-Cell Lymphoma

Juan Pablo Alderuccio, Russ Kuker, Mark K Polar, Fei Yang, Craig H. Moskowitz
Journal: Blood
Blood (2024) 144 (Supplement 1): 1622.
https://doi.org/10.1182/blood-2024-209334
Published: 2024
Journal Articles

Association of Body Composition Factors and Toxicity in Patients with Advanced Stage Hodgkin Lymphoma Receiving BV-AVD

Michele D. Stanchina, Russ Kuker, Sunwoo Han, Fei Yang, Mark K Polar, Jillian Lorayne Lykon, Tracy Crane, Melissa Lopez-Pentecost, Craig H. Moskowitz, Juan Pablo Alderuccio
Journal: Blood
Blood (2024) 144 (Supplement 1): 4423.
https://doi.org/10.1182/blood-2024-203734
Published: 2024
Journal Articles

PET/CT Enables Appropriate Staging in Extranodal Marginal Zone Lymphoma

Juan Pablo Alderuccio, Michele D. Stanchina, Jean L. Koff, Isildinha M. Reis, Eduardo Edelman Saul, Melissa C. Larson, Dai Chihara, Wei Zhao, Thomas M. Habermann, Peter Martin, Loretta J. Nastoupil, Jennifer R. Chapman-Fredricks, Andrew L. Feldman, Brian K. Link, Brad S. Kahl, Jonathon B. Cohen, Mark K Polar, Rafael Henneman Sassi, Craig H. Moskowitz, Jonathan W. Friedberg, James R. Cerhan, Russ Kuker, Christopher R. Flowers, Izidore S. Lossos
Journal: Blood
Blood (2023) 142 (Supplement 1): 5134.
https://doi.org/10.1182/blood-2023-179478
Published: 2023